Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
137.8 USD | -0.23% | +0.56% | +0.20% |
Financials (USD)
Sales 2024 * | 9.45B | Sales 2025 * | 9.76B | Capitalization | 15.35B |
---|---|---|---|---|---|
Net income 2024 * | 894M | Net income 2025 * | 962M | EV / Sales 2024 * | 2.06 x |
Net Debt 2024 * | 4.07B | Net Debt 2025 * | 3.5B | EV / Sales 2025 * | 1.93 x |
P/E ratio 2024 * |
17.7
x | P/E ratio 2025 * |
16.2
x | Employees | 44,000 |
Yield 2024 * |
2.09% | Yield 2025 * |
2.15% | Free-Float | 68.24% |
Latest transcript on Quest Diagnostics Incorporated
1 day | +1.48% | ||
1 week | +1.33% | ||
Current month | -0.01% | ||
1 month | +4.08% | ||
3 months | +9.01% | ||
6 months | +4.95% | ||
Current year | +0.20% |
Managers | Title | Age | Since |
---|---|---|---|
James Davis
CEO | Chief Executive Officer | 61 | 13-03-31 |
Sam Samad
DFI | Director of Finance/CFO | 54 | 22-07-10 |
Kristin Wallace
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Denise Morrison
BRD | Director/Board Member | 70 | 19-02-17 |
Timothy Ring
BRD | Director/Board Member | 66 | 11-12-06 |
Gail Wilensky
BRD | Director/Board Member | 80 | 96-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.84% | 0 M€ | +11.39% | - | |
2.17% | 0 M€ | +8.89% | ||
2.05% | 0 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 138.2 | -0.01% | 157 252 |
24-05-09 | 138.2 | +1.48% | 588,254 |
24-05-08 | 136.1 | -0.58% | 612,360 |
24-05-07 | 136.9 | +0.96% | 637,785 |
24-05-06 | 135.6 | -1.27% | 750,586 |
Delayed Quote Nyse, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.20% | 15.35B | |
+18.92% | 84.31B | |
-29.48% | 69.9B | |
+9.65% | 29.06B | |
+1.35% | 17.01B | |
-9.30% | 17.38B | |
+5.25% | 12.91B | |
+68.96% | 12.47B | |
-2.61% | 11.9B | |
-31.58% | 11.83B |
- Stock Market
- Equities
- DGX Stock